Raymond James & Associates’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-12,133
| Closed | -$403K | – | 3978 |
|
2022
Q4 | $403K | Sell |
12,133
-6,875
| -36% | -$228K | ﹤0.01% | 3014 |
|
2022
Q3 | $599K | Buy |
19,008
+6,414
| +51% | +$202K | ﹤0.01% | 2733 |
|
2022
Q2 | $383K | Buy |
12,594
+1,097
| +10% | +$33.4K | ﹤0.01% | 3056 |
|
2022
Q1 | $298K | Sell |
11,497
-471
| -4% | -$12.2K | ﹤0.01% | 3391 |
|
2021
Q4 | $244K | Sell |
11,968
-11,198
| -48% | -$228K | ﹤0.01% | 3548 |
|
2021
Q3 | $446K | Sell |
23,166
-54,163
| -70% | -$1.04M | ﹤0.01% | 3135 |
|
2021
Q2 | $1.72M | Sell |
77,329
-12,059
| -13% | -$267K | ﹤0.01% | 2205 |
|
2021
Q1 | $2.35M | Sell |
89,388
-6,465
| -7% | -$170K | ﹤0.01% | 1908 |
|
2020
Q4 | $1.79M | Buy |
95,853
+5,367
| +6% | +$100K | ﹤0.01% | 1951 |
|
2020
Q3 | $1.54M | Sell |
90,486
-19,106
| -17% | -$324K | ﹤0.01% | 1917 |
|
2020
Q2 | $2.55M | Buy |
109,592
+12,736
| +13% | +$297K | ﹤0.01% | 1575 |
|
2020
Q1 | $814K | Buy |
+96,856
| New | +$814K | ﹤0.01% | 2116 |
|
2015
Q4 | – | Sell |
-14,167
| Closed | -$242K | – | 2409 |
|
2015
Q3 | $242K | Buy |
+14,167
| New | +$242K | ﹤0.01% | 2191 |
|
2013
Q3 | – | Sell |
-30,096
| Closed | -$647K | – | 1990 |
|
2013
Q2 | $647K | Buy |
+30,096
| New | +$647K | 0.01% | 1375 |
|